Literature DB >> 9813201

Analysis of intracellular trafficking and interactions of cytoplasmic HIV-1 Rev mutants in living cells.

R H Stauber1, E Afonina, S Gulnik, J Erickson, G N Pavlakis.   

Abstract

The HIV-1 Rev protein is an essential nuclear regulatory viral protein. Rev mutants that are able to block wild-type (WT) Rev activity in trans have been reported and used in antiviral approaches. Not only nuclear but also cytoplasmic Rev mutants were described and suspected to be transdominant by retaining WT Rev in the cytoplasm. To investigate their potential for cytoplasmic retention, we studied the localization, trafficking, and interactions of cytoplasmic Rev mutants containing mutations in the N-terminal multifunctional domain. Using a novel dual-color autofluorescent protein-tagging system, we found that coexpression of the nucleolar blue-tagged WT Rev protein together with green-labeled cytoplasmic Rev mutants did not result in the retention of WT Rev in the cytoplasm but, on the contrary, in colocalization of the mutants to the nucleolus. A combination of mutations abolished the interaction with WT Rev, defining two domains important for Rev protein interaction. The identified domains were also essential for specific Rev responsive element (RRE) RNA binding and nuclear retention. Inactivation of the nuclear export signal shifted the steady-state distribution of the mutants from the cytoplasm to the nucleus, indicating their capability for nucleo-cytoplasmic shuttling. The cytoplasmic mutants were not transdominant compared to the nuclear mutant RevM10BL. These results emphasize that efficient oligomerization with WT Rev combined with RRE-specific RNA binding are prerequisites for effective transdominance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9813201     DOI: 10.1006/viro.1998.9295

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  18 in total

1.  The adenovirus type 5 E1B-55K oncoprotein actively shuttles in virus-infected cells, whereas transport of E4orf6 is mediated by a CRM1-independent mechanism.

Authors:  T Dosch; F Horn; G Schneider; F Krätzer; T Dobner; J Hauber; R H Stauber
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  A synthetic HIV-1 Rev inhibitor interfering with the CRM1-mediated nuclear export.

Authors:  Dirk Daelemans; Elena Afonina; Jakob Nilsson; Gudrun Werner; Jorgen Kjems; Erik De Clercq; George N Pavlakis; Anne-Mieke Vandamme
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-09       Impact factor: 11.205

3.  Identification of a domain in human immunodeficiency virus type 1 rev that is required for functional activity and modulates association with subnuclear compartments containing splicing factor SC35.

Authors:  D M D'Agostino; T Ferro; L Zotti; F Meggio; L A Pinna; L Chieco-Bianchi; V Ciminale
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  Kinetic and molecular analysis of nuclear export factor CRM1 association with its cargo in vivo.

Authors:  Dirk Daelemans; Sylvain V Costes; Stephen Lockett; George N Pavlakis
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

5.  Depletion of hnRNP A2/B1 overrides the nuclear retention of the HIV-1 genomic RNA.

Authors:  Heather Gordon; Lara Ajamian; Fernando Valiente-Echeverrìa; Kathy Lévesque; William F Rigby; Andrew J Mouland
Journal:  RNA Biol       Date:  2013-09-30       Impact factor: 4.652

6.  A mutant Tat protein provides strong protection from HIV-1 infection in human CD4+ T cells.

Authors:  Ann Apolloni; Min-Husan Lin; Haran Sivakumaran; Dongsheng Li; Michael H R Kershaw; David Harrich
Journal:  Hum Gene Ther       Date:  2013-03-01       Impact factor: 5.695

7.  High-content positional biosensor screening assay for compounds to prevent or disrupt androgen receptor and transcriptional intermediary factor 2 protein-protein interactions.

Authors:  Yun Hua; Tong Ying Shun; Christopher J Strock; Paul A Johnston
Journal:  Assay Drug Dev Technol       Date:  2014-09       Impact factor: 1.738

8.  Diminished rev-mediated stimulation of human immunodeficiency virus type 1 protein synthesis is a hallmark of human astrocytes.

Authors:  E Ludwig; F C Silberstein; J van Empel; V Erfle; M Neumann; R Brack-Werner
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

9.  Dual roles for an arginine-rich motif in specific genome recognition and localization of viral coat protein to RNA replication sites in flock house virus-infected cells.

Authors:  P Arno Venter; Dawn Marshall; Anette Schneemann
Journal:  J Virol       Date:  2009-01-21       Impact factor: 5.103

10.  Structural model of the Rev regulatory protein from equine infectious anemia virus.

Authors:  Yungok Ihm; Wendy O Sparks; Jae-Hyung Lee; Haibo Cao; Susan Carpenter; Cai-Zhuang Wang; Kai-Ming Ho; Drena Dobbs
Journal:  PLoS One       Date:  2009-01-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.